These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
113 related items for PubMed ID: 8422091
1. Blunted growth hormone responses to growth hormone-releasing factor and to clonidine in panic disorder. Tancer ME, Stein MB, Black B, Uhde TW. Am J Psychiatry; 1993 Feb; 150(2):336-7. PubMed ID: 8422091 [Abstract] [Full Text] [Related]
2. Evidence for hypothalamo-growth hormone dysfunction in panic disorder: profile of growth hormone (GH) responses to clonidine, yohimbine, caffeine, glucose, GRF and TRH in panic disorder patients versus healthy volunteers. Uhde TW, Tancer ME, Rubinow DR, Roscow DB, Boulenger JP, Vittone B, Gurguis G, Geraci M, Black B, Post RM. Neuropsychopharmacology; 1992 Feb; 6(2):101-18. PubMed ID: 1610485 [Abstract] [Full Text] [Related]
3. Growth hormone response to intravenous clonidine in social phobia: comparison to patients with panic disorder and healthy volunteers. Tancer ME, Stein MB, Uhde TW. Biol Psychiatry; 1993 Nov 01; 34(9):591-5. PubMed ID: 8292687 [Abstract] [Full Text] [Related]
4. Blunted growth hormone response to peripheral infusion of human growth hormone-releasing factor in patients with panic disorder. Rapaport MH, Risch SC, Gillin JC, Golshan S, Janowsky DS. Am J Psychiatry; 1989 Jan 01; 146(1):92-5. PubMed ID: 2492166 [Abstract] [Full Text] [Related]
5. Persistence of blunted human growth hormone response to clonidine in fluoxetine-treated patients with panic disorder. Coplan JD, Papp LA, Martinez J, Pine D, Rosenblum LA, Cooper T, Liebowitz MR, Gorman JM. Am J Psychiatry; 1995 Apr 01; 152(4):619-22. PubMed ID: 7694915 [Abstract] [Full Text] [Related]
6. Alpha 2-adrenergic receptor sensitivity in panic disorder: I. GH response to GHRH and clonidine stimulation in panic disorder. Brambilla F, Perna G, Garberi A, Nobile P, Bellodi L. Psychoneuroendocrinology; 1995 Apr 01; 20(1):1-9. PubMed ID: 7838898 [Abstract] [Full Text] [Related]
7. Growth-hormone response to clonidine in panic disorder patients in comparison to patients with major depression and healthy controls. Gann H, Riemann D, Stoll S, Berger M, Müller WE. Pharmacopsychiatry; 1995 May 01; 28(3):80-3. PubMed ID: 7568369 [Abstract] [Full Text] [Related]
8. Growth hormone-releasing factor stimulation test in depression. Krishnan KR, Manepalli AN, Ritchie JC, Rayasam K, Melville ML, Daughtry G, Thorner MO, Rivier JE, Vale WW, Nemeroff CB. Am J Psychiatry; 1988 Jan 01; 145(1):90-2. PubMed ID: 2827532 [Abstract] [Full Text] [Related]
9. Endocrine, cardiovascular, and behavioral responses to clonidine in patients with panic disorder. Abelson JL, Glitz D, Cameron OG, Lee MA, Bronzo M, Curtis GC. Biol Psychiatry; 1992 Jul 01; 32(1):18-25. PubMed ID: 1391293 [Abstract] [Full Text] [Related]
10. Comparative effect of clonidine and growth hormone (GH)-releasing hormone on GH secretion in adult patients on chronic glucocorticoid therapy. Giustina A, Buffoli MG, Bussi AR, Doga M, Girelli A, Pizzocolo G, Pozzi A, Wehrenberg WB. Horm Metab Res; 1992 May 01; 24(5):240-3. PubMed ID: 1398465 [Abstract] [Full Text] [Related]
11. Growth hormone (GH) response to clonidine and growth hormone releasing factor (GRF) in normal controls. Tancer ME, Stein MB, Uhde TW. Psychoneuroendocrinology; 1990 May 01; 15(4):253-9. PubMed ID: 2087535 [Abstract] [Full Text] [Related]
12. Growth hormone response to growth hormone-releasing hormone and clonidine in depression. Gann H, Riemann D, Stoll S, Berger M, Müller WE. Biol Psychiatry; 1995 Sep 01; 38(5):325-9. PubMed ID: 7495927 [Abstract] [Full Text] [Related]
13. Growth hormone secretion in response to the new centrally acting antihypertensive agent moxonidine in normal human subjects: comparison to clonidine and GHRH. Bamberger CM, Mönig H, Mill G, Gödde E, Schulte HM. Exp Clin Endocrinol Diabetes; 1995 Sep 01; 103(3):205-8. PubMed ID: 7584524 [Abstract] [Full Text] [Related]
14. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men. Devesa J, Diaz MJ, Tresguerres JA, Arce V, Lima L. J Clin Endocrinol Metab; 1991 Aug 01; 73(2):251-6. PubMed ID: 1677361 [Abstract] [Full Text] [Related]
15. Stimulatory tests of growth hormone secretion in prepubertal major depression: depressed versus normal children. Ryan ND, Dahl RE, Birmaher B, Williamson DE, Iyengar S, Nelson B, Puig-Antich J, Perel JM. J Am Acad Child Adolesc Psychiatry; 1994 Aug 01; 33(6):824-33. PubMed ID: 8083139 [Abstract] [Full Text] [Related]
16. Effect of growth hormone-releasing hormone and clonidine on growth hormone release in type 1 diabetic patients. Giampietro O, Ferdeghini M, Miccoli R, Locatelli V, Cerri M, Yanaihara N, Navalesi R, Müller EE. Horm Metab Res; 1987 Dec 01; 19(12):636-41. PubMed ID: 3126122 [Abstract] [Full Text] [Related]
17. Suppression of the growth hormone (GH) response to clonidine and GH-releasing hormone by exogenous GH. Nakamoto JM, Gertner JM, Press CM, Hintz RL, Rosenfeld RG, Genel M. J Clin Endocrinol Metab; 1986 May 01; 62(5):822-6. PubMed ID: 3082919 [Abstract] [Full Text] [Related]